Adline Chem Lab Board of Directors
Get the latest insights into the leadership at Adline Chem Lab. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Vrushank Balkrushna Patel | Executive Non Independent Director |
| Nilay Jitendrabhai Vaghasiya | Executive Non Independent Director |
| Dhawal Akhilesh Deopura | Non Executive Independent Director |
| Sarang Pathak | Managing Director |
| Shivani Pathak | Non Executive Independent Director |
| Him Vyas | Non Executive Independent Director |
| Krish Patel | Non Executive Independent Director |
| Gokani Gopika Mukesh | Company Secretary and Compliance Officer |
Adline Chem Lab FAQs
The board at Adline Chem Lab consists of experienced professionals, including Vrushank Balkrushna Patel, Nilay Jitendrabhai Vaghasiya, and others, overseeing the company’s strategic and corporate governance.
Directors at Adline Chem Lab are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Vrushank Balkrushna Patel is the current chairman at Adline Chem Lab.
Executive directors at Adline Chem Lab are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Adline Chem Lab adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Adline Chem Lab, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
